In addition, the ATGL protein levels, which were reduced in HepG2 cells treated with OA for 12 days without affecting the transcriptional level, could be restored by MG132 treatment (Figure 2F and G), suggesting that ATGL is also degraded through the proteasome pathway in hepatic steatosis. The gene discussed is PNPLA2; the disease is fatty liver disease.